S02E02: A Conversation with AbCellera CEO, Carl Hansen
In Episode 2 of our 2nd season, Wall Scholars Dr. Purang Abolmaesumi and Dr. Lara Boyd sit down with Dr. Carl Hansen, CEO of AbCellera Biologics, for a conversation about his unique career path and how he transitioned from academic to innovative corporate leader.
Dr. Hansen works at the interface of engineering, biology and computation. He is the co-founder and CEO of AbCellera Biologics a technology company that discovered the world’s first antibody therapy authorized to treat mild to moderate COVID-19. His significant contributions to society are represented in 90 peer-reviewed manuscripts and abstracts, 75+ patent applications, eight commercial products, two of BC’s fastest-growing biotechnology companies and nearly 300 new jobs in BC.
This episode was produced remotely with Hansen, Abolmaesumi and Boyd recording from separate locations.
Learn more about Abcellera Biologics.
Listen to the episode below and make sure to subscribe wherever you get your podcasts.
The Peter Wall Institute for Advanced Studies is proud to present the Ways of Knowing podcast. Join us as we make sense of the world though conversations with scholars and artists. Every episode, our Wall Scholars explore new and different ways to make sense of the world through thought-provoking conversations with scholars and artists.